The Convenient Exception
Modern medicine and the supplement world like to pretend they are enemies. In reality, they often use the same trick.
They just apply it in opposite directions.
When a blockbuster treatment fails, the script is familiar. The treatment still works. The studies still stand. The protocol remains sound. You, unfortunately, are the exception. Your body was difficult. Your case was unusual. The machine is not questioned. The patient is.
When a supplement or some low-status intervention actually works, the script flips. Now the burden is reversed. The benefit does not really count. It is anecdotal. It is placebo. It is coincidence. It may have helped you, but that only proves that you are, once again, the exception.
With official medicine, if it does not work, you are the exception.
With unofficial medicine, if it does work, you are the exception.
Either way, the system protects its prestige.
This is not a scientific principle. It is a status reflex.
The pharmaceutical world has mastered the language of legitimacy. It speaks in guidelines, approvals, endpoints, and polished certainty. Even when outcomes are mediocre, it retains authority because its failures are absorbed into the noble fog of complexity. Real medicine is complicated, you are told. Responses vary. Nothing works for everyone. Fair enough. That is true.
But the same generosity is rarely extended to anything outside the official cathedral.
There, variability suddenly becomes disqualifying. If a non-patented substance helps a subset of people, that is not treated as a clue. It is treated as an embarrassment. If it does not work for everyone, it is dismissed as unreliable. The standard quietly changes. What counts as acceptable variation in a patented intervention becomes fatal weakness in a supplement.
The asymmetry is obvious once you see it.
A high-status treatment can fail and remain respectable.
A low-status treatment can help and remain unserious.
This does not mean every supplement works. Most do not. The marketplace is full of nonsense, fairy dust, and expensive urine. But that is not the point. The point is that the standards of interpretation are not applied evenly.
Mainstream medicine gets to be probabilistic and still call itself science.
Supplements are expected to be universal before they are allowed to be taken seriously.
That is absurd.
No serious person believes human biology is universal in response. People react differently to antidepressants, blood-pressure drugs, painkillers, statins, anaesthesia, caffeine, alcohol, and exercise. But somehow the moment a non-mainstream intervention helps someone, we are told that this proves nothing because it did not help everyone else.
What this really reveals is not scientific caution. It reveals a hierarchy of respectability.
If a treatment comes wrapped in patents, institutions, white coats, and a billing code, its variability is called nuance.
If it comes in a jar, its variability is called nonsense.
This is why many people no longer trust the official story. Not because they reject science, but because they can smell the selective skepticism. They see one class of interventions granted endless interpretive mercy, while another is mocked for the same inconsistency.
In both cases, the individual is sacrificed to protect the narrative.
If the blockbuster fails, the narrative survives and you become the outlier.
If the supplement succeeds, the narrative survives and you become the outlier.
The system wins twice.
Perhaps the more honest position would be simpler and less theatrical. Most interventions work for some people, fail for others, and the real challenge is to understand for whom, when, and why. But that would require humility, and humility is bad for marketing.
Certainty sells better.
So we continue with the farce. The patented failure remains respectable. The unpatented success remains suspicious. And the patient, as usual, is left somewhere in the middle, paying for both stories.